Repair and regeneration of ocular tissue using postpartum-derived cells
US10744164B2 · kind B2 · utility
0Cited by
105References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2016 |
| Grant date | Aug 18, 2020 |
| Priority date | — |
| Expiry date | Jan 11, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cells derived from postpartum umbilicus and placenta are disclosed. Pharmaceutical compositions, devices and methods for the regeneration or repair of ocular tissue using the postpartum-derived cells are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.